Annual period ending Sep 27, 2025. These figures are calculated from the available SEC records and displayed independently of the period selected for the table.
These figures describe the results, not their causes. Read the original filing to investigate recurring operations, one-off effects and management’s outlook.
SEC · Reported statement presentation; original units are preserved.
Scale applies to monetary amounts; share counts and per-share values retain their units.
| Reported line item | TTM 2022Sep 24 | TTM 2022Dec 31 | TTM 2023Apr 1 | TTM 2023Jul 1 | TTM 2023Sep 30 | TTM 2023Dec 30 | TTM 2024Mar 30 | TTM 2024Jun 29 |
|---|---|---|---|---|---|---|---|---|
Contract revenueUSD | 394.33B | 387.54B | 385.1B | 383.93B | 383.29B | 385.71B | 381.62B | 385.6B |
Common Stock, Dividends, Per Share, DeclaredUSD/shares | 0.9 | — | — | — | 0.94 | — | — | — |
Cost of salesUSD | 223.55B | 220.67B | 218.81B | 217.12B | 214.14B | 212.04B | 207.66B | 208.37B |
Gross profitUSD | 170.78B | 166.87B | 166.29B | 166.82B | 169.15B | 173.67B | 173.97B | 177.23B |
Research & developmentUSD | 26.25B | 27.65B | 28.72B | 29.37B | 29.92B | 29.9B | 30.35B | 30.91B |
Selling & administrationUSD | 25.09B | 25.25B | 25.26B | 25.22B | 24.93B | 25.11B | 25.38B | 25.73B |
Operating expensesUSD | 51.35B | 52.91B | 53.98B | 54.59B | 54.85B | 55.01B | 55.73B | 56.64B |
Operating incomeUSD | 119.44B | 113.97B | 112.3B | 112.23B | 114.3B | 118.66B | 118.24B | 120.59B |
Non-operating income / expenseUSD | -334M | -480M | -576M | -831M | -565M | -222M | -128M | 279M |
Pre-tax incomeUSD | 119.1B | 113.49B | 111.73B | 111.4B | 113.74B | 118.44B | 118.11B | 120.87B |
Income taxUSD | 19.3B | 18.31B | 17.41B | 16.64B | 16.74B | 17.52B | 17.72B | 18.92B |
Net incomeUSD | 99.8B | 95.17B | 94.32B | 94.76B | 97B | 100.91B | 100.39B | 101.96B |
Basic EPSUSD/shares | 6.15 | — | — | — | 6.16 | — | — | — |
Diluted EPSUSD/shares | 6.11 | — | — | — | 6.13 | — | — | — |
Basic sharesshares | 16.22B | — | — | — | 15.74B | — | — | — |
Diluted sharesshares | 16.33B | — | — | — | 15.81B | — | — | — |
| Reported line item | TTM 2022Sep 24 | TTM 2022Dec 31 | TTM 2023Apr 1 | TTM 2023Jul 1 | TTM 2023Sep 30 | TTM 2023Dec 30 | TTM 2024Mar 30 | TTM 2024Jun 29 |
|---|---|---|---|---|---|---|---|---|
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of TaxUSD | -1.51B | -1.17B | -1.24B | -903M | -765M | -443M | -670M | -358M |
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after TaxUSD | -12.1B | -10.03B | -2.99B | -182M | 1.56B | 3.71B | 2.3B | 2.91B |
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of TaxUSD | -205M | -279M | -287M | -250M | -253M | -263M | -260M | -232M |
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and TaxUSD | -11.9B | -9.75B | -2.71B | 68M | 1.82B | 3.97B | 2.56B | 3.14B |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to ParentUSD | -11.27B | -11.99B | -5.25B | -2.5B | -343M | 3.53B | 2.79B | 3.39B |
Comprehensive Income (Loss), Net of Tax, Attributable to ParentUSD | 88.53B | 83.19B | 89.07B | 92.26B | 96.65B | 104.45B | 103.18B | 105.34B |
Other Comprehensive Income (Loss), Derivative Instrument, Gain (Loss), before Reclassification, after TaxUSD | 3.21B | 1.86B | 1.52B | 1.17B | 323M | 780M | 1.25B | 1.15B |
Other Comprehensive Income (Loss), Derivative Instrument, Gain (Loss), Reclassification, after TaxUSD | 1.07B | 2.93B | 2.82B | 2.84B | 1.72B | 774M | 351M | 541M |
Other Comprehensive Income (Loss), Derivative Instrument, Gain (Loss), after Reclassification and TaxUSD | 2.14B | -1.07B | -1.31B | -1.67B | -1.39B | 6M | 898M | 605M |
The income statement tracks activity over a period, the balance sheet shows a position at a date, and cash flow explains movements in cash. A profit does not necessarily arrive as cash in the same period. Compare receivables, investment spending and financing alongside earnings.
Annual, quarterly and trailing-twelve-month views answer different questions. Seasonality can make adjacent quarters misleading. Check the fiscal dates and reporting currency before comparing figures; company-specific line items can differ from standard summaries.
Check whether changes in revenue are accompanied by changes in margins and operating cash flow. The figures alone cannot establish whether a movement came from pricing, acquisitions or a one-off item. Read the linked filing for management’s explanation and the accounting notes.
Valuations are estimates, not investment advice. Figures may use different source dates.
